Polar Asset Management Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-322,800
| Closed | -$3.17M | – | 836 |
|
|
2023
Q4 | $3.17M | Sell |
322,800
-510,200
| -61% | -$5.01M | 0.05% | 274 |
|
|
2023
Q3 | $6.96M | Buy |
833,000
+266,300
| +47% | +$2.22M | 0.15% | 172 |
|
|
2023
Q2 | $7.54M | Sell |
566,700
-95,000
| -14% | -$1.26M | 0.14% | 181 |
|
|
2023
Q1 | $7.66M | Buy |
+661,700
| New | +$7.66M | 0.12% | 211 |
|
|
2022
Q2 | – | Sell |
-476,500
| Closed | -$4.34M | – | 1364 |
|
|
2022
Q1 | $4.34M | Buy |
+476,500
| New | +$4.34M | 0.05% | 453 |
|
|
2019
Q3 | – | Sell |
-475,000
| Closed | -$2.87M | – | 394 |
|
|
2019
Q2 | $2.87M | Buy |
475,000
+380,000
| +400% | +$2.3M | 0.05% | 198 |
|
|
2019
Q1 | $687K | Buy |
+95,000
| New | +$687K | 0.02% | 219 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 333 |
|